<p>Prevalence and Associated Factors of Dyslipidemia Among Adults with Type 2 Diabetes Mellitus in Saudi Arabia</p>-Reference-Cited by-同舟云学术

Prevalence and Associated Factors of Dyslipidemia Among Adults with Type 2 Diabetes Mellitus in Saudi Arabia

Published:2020-10 Issue: Volume:Volume 13 Page:4033-4040
ISSN:1178-7007
Container-title:Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
language:en
Short-container-title:DMSO

Author:

Alzaheb Riyadh A^ORCID,Altemani Abdullah H

Publisher

Informa UK Limited

Subject

Pharmacology,Internal Medicine

Reference36 articles.

1. International Diabetes Federation. IDF diabetes atlas. 6th edition. Brussels, Belgium: International Diabetes Federation; 2013. Available from: http://www.idf.org/diabetesatlas. Accessed October 22, 2020.

2. Diabetes epidemic sweeping the Arab world

3. Lipid Abnormalities in Type 2 Diabetes Mellitus Patients with Overt Nephropathy

4. Dyslipidemia and associated factors among diabetic patients attending Durame General Hospital in Southern Nations, Nationalities, and People’s Region

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The comorbidity burden of type 2 diabetes mellitus (T2DM): sex differences and associated factors among 830 cases in North-Eastern Morocco;Diabetology International;2024-08-14

2. The Effect of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists on the Lipid Profile of Diabetic Patients Using Statins: A Retrospective Cohort Study in the Diabetic Center of King Salman Bin Abdulaziz Hospital, Saudi Arabia;Cureus;2024-07-27

3. Microalbuminuria and lipid variations in adolescents diagnosed with type 1 diabetes;Heliyon;2024-06

4. Budget impact analysis for three glucagon-like peptide-1 receptor agonist-based therapies for type 2 diabetes mellitus management in Saudi Arabia;Journal of Medical Economics;2024-03-11

5. The Burden of Dyslipidemia and Determinant Factors Among Type 2 Diabetes Mellitus Patients at Hawassa University Comprehensive Specialized Hospital, Hawassa, Ethiopia;Diabetes, Metabolic Syndrome and Obesity;2024-02